Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-၀.၂၁%
၁,၀၉၁.၅၁
-၂.၃၀
-၀.၂၁%
—၁,၀၉၃.၈၁၁,၀၉၆.၅၂၁,၁၀၀.၂၂၁,၀၉၁.၅၁——
SIXC
Communications
SIXC
Communications
SIXC
+၀.၂၂%
၆၁၀.၁၁
+၁.၃၄
+၀.၂၂%
—၆၀၈.၇၇၆၀၈.၇၇၆၁၂.၉၇၆၀၈.၇၇——
SIXE
Energy
SIXE
Energy
SIXE
-၁.၃၄%
၁,၂၃၇.၉၈
-၁၆.၈၃
-၁.၃၄%
—၁,၂၅၄.၈၁၁,၂၅၃.၀၁၁,၂၅၃.၈၇၁,၂၂၆.၃၃——
SIXI
Industrials
SIXI
Industrials
SIXI
-၀.၉၃%
၁,၇၄၄.၇၁
-၁၆.၄၀
-၀.၉၃%
—၁,၇၆၁.၁၁၁,၇၆၄.၂၇၁,၇၆၆.၈၈၁,၇၄၄.၇၁——
SIXM
Financials
SIXM
Financials
SIXM
-၀.၃၇%
၆၄၀.၁၈
-၂.၄၀
-၀.၃၇%
—၆၄၂.၅၈၆၄၄.၈၇၆၄၈.၄၈၆၄၀.၁၈——
SIXR
Staples
SIXR
Staples
SIXR
-၀.၁၈%
၈၄၉.၅၈
-၁.၅၅
-၀.၁၈%
—၈၅၁.၁၃၈၅၅.၆၆၈၅၈.၇၅၈၄၅.၅၆——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-၀.၂၃%
၂၁၇.၄၈
-၀.၅၀
-၀.၂၃%
—၂၁၇.၉၈၂၁၇.၉၈၂၁၈.၆၅၂၁၆.၈၈——
SIXT
Technology
SIXT
Technology
SIXT
+၁.၅၂%
၃,၂၆၀.၆၉
+၄၈.၈၆
+၁.၅၂%
—၃,၂၁၁.၈၃၃,၂၂၇.၂၁၃,၂၆၈.၃၈၃,၂၂၆.၅၅——
SIXU
Utilities
SIXU
Utilities
SIXU
-၀.၆၉%
၉၄၂.၄၅
-၆.၅၃
-၀.၆၉%
—၉၄၈.၉၈၉၄၈.၅၈၉၅၇.၈၃၉၄၁.၉၇——
SIXV
Health care
SIXV
Health care
SIXV
-၀.၅၂%
၁,၄၆၆.၈၀
-၇.၇၂
-၀.၅၂%
—၁,၄၇၄.၅၂၁,၄၇၉.၀၃၁,၄၈၁.၀၄၁,၄၆၆.၈၀——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+၀.၂၂%
၂,၃၉၇.၅၀
+၅.၃၈
+၀.၂၂%
—၂,၃၉၂.၁၂၂,၃၉၆.၉၅၂,၄၂၁.၂၂၂,၃၈၂.၃၂——
Q1 2026 earnings • released • EPS beat +၈.၀၄% • Revenue beat +၀.၅၅%
See results
AMGN:NASDAQ
Amgen Inc
၃၂၉.၈၂ US$
-၄.၇၅%
(-၁၆.၄၃) 1D
၃၂၉.၅၇ US$
-၀.၀၈% (-၀.၂၅)
After hours
Closed: မေ ၁, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AMGN...
Open
၃၃၂.၅၂ US$
High
၃၃၇.၀၀ US$
Low
၃၂၄.၆၃ US$
Mkt. cap
ဋေ ၁.၇၈ သ
Avg. vol.
၂.၆၀ သန်း
Volume
၃.၈၂ သန်း
Dividend
၃.၀၆%
Quarterly dividend
၂.၅၂ US$
Ex dividend date
၂၀၂၆ မေ ၁၅
P/E ratio
၂၃.၁၈
52-wk high
၃၉၁.၂၉ US$
52-wk low
၂၆၁.၄၃ US$
EPS
၁၄.၂၃ US$
Beta
၀.၄၇
Shares outstanding
၅၃.၉၇ ကုဋေ
No. of employees
၃ သောင်း
News stories
From sources across the web
TipRanks
TipRanks
·
ပြီးခဲ့သည့် ၂၇ မိနစ်
Amgen Earnings Call Highlights Growth Engines, Tax Risk
GuruFocus
GuruFocus
·
ပြီးခဲ့သည့် ၃ နာရီ
Amgen Inc (AMGN) Shares Fall 4.8% -- What GF Score of 93 Tells I
MarketWatch
MarketWatch
·
ပြီးခဲ့သည့် ၄ နာရီ
Amgen Inc. stock underperforms Friday when compared to competitors
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၅ နာရီ
Truist Financial Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics. The company's major products are Prolia and XGEVA for treatment of osteoporosis and bone diseases, Enbrel for treatment of autoimmune diseases, Repatha for treatment of hyperlipidemia, Otezla for treatment of psoriasis and psoriatic arthritis, Tepezza to treat Graves' ophthalmopathy, Evenity to treat osteoporosis, Kyprolis to treat cancer, Nplate to regulate platelet production, and Aranesp to stimulate erythropoiesis. Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection. The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. The company is ranked 134th on the Fortune 500 and 202nd on the Forbes Global 2000. Wikipedia
About Amgen Inc
CEORobert A. Bradway
Employees၃.၁၅ သောင်း
Founded၁၉၈၀ ဧ ၈
Headquartersသောင်စင်အုက်စ်, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteamgen.com
Last report
၂၀၂၆ ဧ ၃၀
Fiscal Period
Q1 2026
Normalized EPS / Estimate
၅.၁၅/ (၄.၇၇ est.)USD
+၈.၀၄%beat
Revenue / Estimate
၈၆၁.၈၀ ဋေ/ (၈၅၇.၀၆ ဋေ est.)USD
+၀.၅၅%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ မတ်
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
Revenue
၈၁၄.၉၀ ဋေ
၉၁၇.၉၀ ဋေ
၉၅၅.၇၀ ဋေ
၉၈၆.၆၀ ဋေ
Cost of goods sold
၂၆၀.၅၀ ဋေ
၂၆၇.၂၀ ဋေ
၂၇၄.၄၀ ဋေ
၂၆၇.၆၀ ဋေ
Cost of revenue
၂၆၀.၅၀ ဋေ
၂၆၇.၂၀ ဋေ
၂၇၄.၄၀ ဋေ
၂၆၇.၆၀ ဋေ
Research and development expenses
၁၄၈.၆၀ ဋေ
၁၇၄.၄၀ ဋေ
၁၉၀.၀၀ ဋေ
၂၁၄.၂၀ ဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁၆၈.၇၀ ဋေ
၁၆၉.၁၀ ဋေ
၁၇၂.၀၀ ဋေ
၁၉၅.၂၀ ဋေ
Operating expense
၃၂၀.၃၀ ဋေ
၃၅၀.၃၀ ဋေ
၃၅၄.၉၀ ဋေ
၄၁၇.၆၀ ဋေ
Total operating expenses
၅၈၀.၈၀ ဋေ
၆၁၇.၅၀ ဋေ
၆၂၉.၃၀ ဋေ
၆၈၅.၂၀ ဋေ
Operating income
၂၃၄.၁၀ ဋေ
၃၀၀.၄၀ ဋေ
၃၂၆.၄၀ ဋေ
၃၀၁.၄၀ ဋေ
Other non operating income
-၃.၆၀ ကုဋေ
-၁၁.၃၀ ကုဋေ
၁၈.၁၀ ကုဋေ
၁၄.၃၀ ကုဋေ
EBT including unusual items
၁၉၇.၃၀ ဋေ
၁၅၆.၈၀ ဋေ
၃၉၂.၁၀ ဋေ
၁၅၁.၄၀ ဋေ
EBT excluding unusual items
၁၆၆.၅၀ ဋေ
၂၃၆.၉၀ ဋေ
၂၇၂.၁၀ ဋေ
၂၅၀.၉၀ ဋေ
Income tax expense
၂၄.၃၀ ကုဋေ
၁၃.၆၀ ကုဋေ
၇၀.၅၀ ကုဋေ
၁၈.၁၀ ကုဋေ
Effective tax rate
၁၂.၃၂%
၈.၆၇%
၁၇.၉၈%
၁၁.၉၆%
Other operating expenses
၃.၀၀ ကုဋေ
၆.၈၀ ကုဋေ
-၇.၁၀ ကုဋေ
၈.၂၀ ကုဋေ
Net income
၁၇၃.၀၀ ဋေ
၁၄၃.၂၀ ဋေ
၃၂၁.၆၀ ဋေ
၁၃၃.၃၀ ဋေ
Net profit margin
၂၁.၂၃%
၁၅.၆၀%
၃၃.၆၅%
၁၃.၅၁%
Earnings per share
၄.၉၀
၆.၀၂
၅.၆၄
၅.၂၉
Interest and investment income
-
-
-
၄၀.၈၀ ကုဋေ
Interest expense
-၇၂.၃၀ ကုဋေ
-၆၉.၄၀ ကုဋေ
-၆၈.၅၀ ကုဋေ
-၁၀၆.၁၀ ဋေ
Net interest expenses
-၇၂.၃၀ ကုဋေ
-၆၉.၄၀ ကုဋေ
-၆၈.၅၀ ကုဋေ
-၆၅.၃၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၃၇၂.၈၀ ဋေ
၄၃၄.၅၀ ဋေ
၄၅၇.၁၀ ဋေ
၄၀၂.၂၀ ဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer